Related Experiment Video
Updated: Mar 9, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
High glucose-induced LIF suppresses osteoblast differentiation via regulating STAT3/SOCS3 signaling
1Department of Orthopaedics, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China.
Abstract:
High glucose (HG) is conceived to regulate bone metabolism in patients with diabetic mellitus (DM). In the present study, we examined the level of leukemia inhibitory factor (LIF), a pleiotropic cytokine in interleukin (IL)-6 family, in T2DM patients and investigated the regulation by HG on the induction of LIF/signal transducer and activator of transcription 3 (STAT3) signaling. Then we determined the regulation of HG and LIF on the osteoblast differentiation via measuring the ALP activity, matrix mineralization, and the expression of alkaline phosphatase (ALP), Runt-related transcription factor 2 (RUNX2), Osteocalcin (OCN) and osteopontin (OPN) in human osteoblast MG-63 cells. In addition, we evaluated the dependence of suppressor of cytokine signaling 3 (SOCS3)/STAT3 signaling in the progress. Results indicated significantly higher serum levels of high-sensitivity C-reactive protein (hsCRP), IL-1β, IL-6 and LIF in T2DM patients. HG induced markedly higher levels of these cytokines in vitro. Furthermore, either HG or LIF reduced the expression of ALP, OCN and RUNX2 in both mRNA and protein levels. In addition, LIF markedly promoted the expression of SOCS3, significantly upregulated the phosphorylation of STAT3 in MG-63 cells; and the downregulation of the four osteogenic differentiation-associated markers were restored by 50 or 100nM STAT3 inhibitor, JSI-124. In summary, this study has shown that LIF is implicated in the HG-mediated inhibition of osteoblast differentiation, via promoting STAT3/SOCS3 signaling. This study may provide insights into the signal pathway of HG-induced bone loss or delayed injured joint healing.
Insights
High glucose in type 2 diabetes mellitus (T2DM) inhibits osteoblast differentiation by increasing leukemia inhibitory factor (LIF). LIF promotes STAT3/SOCS3 signaling, contributing to bone metabolism disruption in T2DM.
Area of Science:
- Endocrinology
- Bone Biology
- Cell Signaling
Background:
- High glucose (HG) impacts bone metabolism in diabetic mellitus (DM).
- Leukemia inhibitory factor (LIF), an IL-6 family cytokine, plays a role in cellular regulation.
- Understanding HG's effect on bone in T2DM is crucial for metabolic bone disease research.
Purpose of the Study:
- To investigate LIF levels in T2DM patients.
- To explore HG's regulation of LIF/STAT3 signaling.
- To determine the impact of HG and LIF on osteoblast differentiation and the role of SOCS3/STAT3 signaling.
Main Methods:
- Measured serum markers (hsCRP, IL-1β, IL-6, LIF) in T2DM patients.
- In vitro study using human osteoblast MG-63 cells exposed to HG.
- Assessed osteogenic markers (ALP, OCN, RUNX2, OPN) at mRNA and protein levels.
- Investigated STAT3 phosphorylation and SOCS3 expression, using STAT3 inhibitor JSI-124.
Main Results:
- T2DM patients exhibited elevated hsCRP, IL-1β, IL-6, and LIF.
- HG increased these cytokine levels in vitro.
- Both HG and LIF reduced osteogenic marker expression (ALP, OCN, RUNX2).
- LIF promoted SOCS3 expression and STAT3 phosphorylation; STAT3 inhibition restored osteogenic markers.
Conclusions:
- LIF is involved in HG-induced inhibition of osteoblast differentiation.
- The mechanism involves the promotion of STAT3/SOCS3 signaling by LIF.
- Findings offer insights into HG-induced bone loss and impaired healing in T2DM.
Related Concept Videos
Cell Specific Gene Expression
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

